Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Revascularization and Insulin Providing (IP)	592
Overall Study	STARTED	Revascularization and Insulin Sensitizing (IS)	584
Overall Study	STARTED	Medical Therapy and Insulin Providing (IP)	593
Overall Study	STARTED	Medical Therapy and Insulin Sensitizing (IS)	599
Overall Study	COMPLETED	Revascularization and Insulin Providing (IP)	575
Overall Study	COMPLETED	Revascularization and Insulin Sensitizing (IS)	574
Overall Study	COMPLETED	Medical Therapy and Insulin Providing (IP)	578
Overall Study	COMPLETED	Medical Therapy and Insulin Sensitizing (IS)	585
Overall Study	NOT COMPLETED	Revascularization and Insulin Providing (IP)	17
Overall Study	NOT COMPLETED	Revascularization and Insulin Sensitizing (IS)	10
Overall Study	NOT COMPLETED	Medical Therapy and Insulin Providing (IP)	15
Overall Study	NOT COMPLETED	Medical Therapy and Insulin Sensitizing (IS)	14

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00006305/flow